Effectiveness and Feasibility of Self-Monitoring for Weight Management in Individuals With Mental Disorders Using Digital Intervention (SWIM Trial)

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study tests whether using a health app (Huawei Health) and a smart body fat scale can help overweight patients with schizophrenia or bipolar disorder lose weight and stay engaged in their health. What We're Testing: 1. Patients who use the app and scale for 4 months (Group 1) will lose more weight than those who use them for 2 months (Group 2). 2. Patients who track their weight, diet, and exercise regularly (≥3 times/week) will lose more weight than those who don't. 3. Seeing weight loss results may motivate patients to keep using the app and scale. How It Works: Patients weigh themselves weekly with the scale (auto-syncs to the app) and upload dietary log in Huawei Health app. The app will gives personalized diet/exercise tips and tracks progress. Doctors and nutritionists provide extra support through messages. Goal: To see if this digital tool + professional support combo works better for long-term weight management.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 60
Healthy Volunteers: f
View:

• Age 18-60 years old, no gender restriction.

• According to ICD-10 to diagnose bipolar disorder or schizophrenia, the researcher judges that the patient is currently in remission, or the condition is stable and can cooperate with the research.

• Currently using at least one antipsychotic or mood stabilizer (e.g. lithium, magnesium valproate, sodium valproate, lamotrigine).

• Currently overweight or obese (body mass index ≥ 24kg/m2) and willing to use health app and smart scales to lose weight.

• The education level of primary school or above, able to understand the content of the scale, and be able to use smart phone proficiently.

• Understand and voluntarily participate in this study, and sign the informed consent form.

Locations
Other Locations
China
Beijing Anding Hospital
RECRUITING
Beijing
Contact Information
Primary
Le Xiao
xiaole373@163.com
+8613466604224
Time Frame
Start Date: 2023-10-31
Estimated Completion Date: 2025-12
Participants
Target number of participants: 204
Treatments
Experimental: Batch 1 (Intervention from Month 3)
3 clinical units (clusters) receiving the combined digital and multidisciplinary intervention starting at Month 3. Each unit includes approximately 34 patients (total n=102) with schizophrenia or bipolar disorder.
Experimental: Batch 2 (Intervention from Month 5)
3 clinical units (clusters) receiving the same intervention starting at Month 5. Each unit includes approximately 34 patients (total n=102) with schizophrenia or bipolar disorder.
Sponsors
Collaborators: Merck Sharp & Dohme LLC
Leads: Capital Medical University

This content was sourced from clinicaltrials.gov